...
首页> 外文期刊>Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology >Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans.
【24h】

Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans.

机译:长期奥曲肽治疗可减轻黑棘皮病严重肥胖患者的高胰岛素血症,体重过重和皮肤损伤。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A boy affected by severe obesity (kg 117, Body Mass Index 37 kg/m2) and acanthosis nigricans, was treated with octreotide for 150 days (50 micrograms x three daily subcutaneous administrations). Before treatment the patient showed an exaggerated insulin (IRI) and C-peptide (CPR) response to a standard meal with a lowering in after-meal CPR/IRI molar ratio. During octreotide treatment both IRI and CPR response was reduced but CPR/IRI molar ratio rised after meal indicating an increase in hepatic insulin removal. Body weight and acanthosis nigricans were sharply reduced during treatment and the reduction was still maintained six months after the cessation of therapy. Furthermore, IRI and CPR response, as well as the behaviour of CPR/IRI molar ratio, remained within normal range. In conclusion long-term octreotide treatment has been able to correct hyperinsulinemia and to reduce body weight and acanthosis nigricans.
机译:对患有严重肥胖症(体重117公斤,体重指数37千克/平方米)和黑棘皮病的男孩进行了奥曲肽治疗150天(50毫克x每天三次皮下给药)。在治疗之前,患者对标准餐食表现出夸张的胰岛素(IRI)和C肽(CPR)反应,且餐后CPR / IRI摩尔比降低。在奥曲肽治疗期间,IRI和CPR反应均降低,但餐后CPR / IRI摩尔比增加,表明肝脏胰岛素去除率增加。在治疗过程中体重和黑棘皮病急剧减少,并且在停止治疗后六个月仍保持这种减少。此外,IRI和CPR响应以及CPR / IRI摩尔比的行为均保持在正常范围内。总之,长期的奥曲肽治疗已经能够纠正高胰岛素血症并减轻体重和黑棘皮病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号